MedPath

PDI-192

Generic Name
PDI-192

An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Vehicle
First Posted Date
2013-04-08
Last Posted Date
2014-05-29
Lead Sponsor
PreCision Dermatology, Inc.
Target Recruit Count
151
Registration Number
NCT01826461
Locations
🇺🇸

Minnesota Clinical Study Center, Fridley, Minnesota, United States

🇺🇸

Virginia Clinical Research, Inc., Norfolk, Virginia, United States

🇺🇸

Academic Dermatology Associates, Albuquerque, New Mexico, United States

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath